Latest News
Conference Coverage
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’s
Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept,...
Latest News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.
Feature
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how...
Conference Coverage
Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 years
This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at...
Conference Coverage
Lupus nephritis: Hopes, questions arise for baricitinib
Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of...
Conference Coverage
ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years after starting a biologic or targeted synthetic DMARD was...
Latest News
Exercise and empathy can help back pain patients in primary care
Recent research suggests limited pain relief from analgesics and antidepressants, but patients report that doctors’ behavior makes a difference in...
Conference Coverage
Multiple successive biologic to biosimilar switches deemed safe and effective
Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.
Latest News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
From the Journals
First prospective study finds pregnancies with Sjögren’s to be largely safe
There was no difference in risk of adverse pregnancy outcomes between women with Sjögren’s and the control group, but these negative outcomes were...
Feature
States move to curb insurers’ prior authorization requirements as federal reforms lag
Doctors and patients in several states would get some relief from burdensome prior authorization requirements if reform legislation becomes law....